Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
about
The effects of occupational exposure to chlorpyrifos on the peripheral nervous system: a prospective cohort studyLoss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome.Further studies toward a mouse model for biochemical assessment of neuropathic potential of organophosphorus compounds.Motor neuron disease due to neuropathy target esterase mutation: enzyme analysis of fibroblasts from human subjects yields insights into pathogenesis.Constructs of human neuropathy target esterase catalytic domain containing mutations related to motor neuron disease have altered enzymatic properties.Microtubule-associated targets in chlorpyrifos oxon hippocampal neurotoxicityComparison of inhibition kinetics of several organophosphates, including some nerve agent surrogates, using human erythrocyte and rat and mouse brain acetylcholinesterase.L- and T-type calcium channel blockers protect against the inhibitory effects of mipafox on neurite outgrowth and plasticity-related proteins in SH-SY5Y cells.Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds.Degradation of organophosphorus neurotoxicity in SY5Y neuroblastoma cells by organophosphorus hydrolase (OPH).Neurofilament 200 as an indicator of differences between mipafox and paraoxon sensitivity in Sy5Y neuroblastoma cells.Effects of Chlorpyrifos and Chlorpyrifos-Methyl on the Outgrowth of Axon-Like Processes, Tubulin, and GAP-43 in N2a Cells.
P2860
Q28393832-DC5ED2A6-C035-4925-B577-8F094C4681DAQ33570147-B4EE42EC-3C52-4CB9-A60A-4E021BB46EFBQ33857017-C4A701B0-25E3-45AB-BF33-1E1E322457A7Q35026581-FDA14EDD-3F40-4D3C-823D-1E235CDB979DQ35026594-020F0DDB-3C49-406D-A332-3C30B4503AA4Q35955917-0EF2B865-D9DD-439A-91CB-17D1E18CA21EQ36723184-8B5E4A71-0017-4C99-828B-FE814988C968Q38598118-8330E523-D4F3-4F31-85CD-0DFD1FB837A2Q39926335-0D25FF33-D99E-4606-A4FB-C44C04C2E500Q40269167-D7979054-1D16-4D80-BF8E-9F8D79F9DCFFQ40543918-336F3532-6B15-4C1E-83E8-59CB82E52E19Q43215645-4049E16B-9E0D-411A-90A7-1DB3BBFC4BC6
P2860
Relative inhibitory potencies of chlorpyrifos oxon, chlorpyrifos methyl oxon, and mipafox for acetylcholinesterase versus neuropathy target esterase.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Relative inhibitory potencies ...... us neuropathy target esterase.
@en
Relative inhibitory potencies ...... us neuropathy target esterase.
@nl
type
label
Relative inhibitory potencies ...... us neuropathy target esterase.
@en
Relative inhibitory potencies ...... us neuropathy target esterase.
@nl
prefLabel
Relative inhibitory potencies ...... us neuropathy target esterase.
@en
Relative inhibitory potencies ...... us neuropathy target esterase.
@nl
P2860
P356
P1476
Relative inhibitory potencies ...... sus neuropathy target esterase
@en
P2093
Timothy J Kropp
P2860
P304
P356
10.1080/15287390306360
P577
2003-06-01T00:00:00Z